Medical Equipment

The Exosome Diagnostic And Therapeutic Market Is Advancing With Support From Exosome Diagnostics And Therapeutics Market Driven By Increasing Prevalence Of Chronic Diseases

May 12, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Does The Forecasted Market Size Of The Exosome Diagnostic And Therapeutic Market Compare Between 2026 And 2030?

The exosome diagnostic and therapeutic market has seen rapid expansion in its size over recent years. It is projected to grow from $0.6 billion in 2025 to $0.77 billion in 2026, achieving a compound annual growth rate (CAGR) of 28.0%. The historical growth in this market can be attributed to significant progress in molecular biology research, increasing investments in regenerative medicine, a surge in academic research on extracellular vesicles, the expansion of biotech research infrastructure, and the growing accessibility of exosome analysis tools.

The exosome diagnostic and therapeutic market is projected to experience substantial expansion in the coming years. It is forecast to reach $2.07 billion by 2030, showing a compound annual growth rate (CAGR) of 28.0%. This growth during the forecast period is fueled by several factors, including the escalating clinical translation of exosome therapies, a rising demand for personalized medicine solutions, the expansion of AI-enabled exosome data analysis, a growing pharmaceutical interest in biologic delivery systems, and increasing regulatory clarity for advanced therapies. Notable trends anticipated in this period encompass the expanded use of exosomes for targeted drug delivery, a surge in the adoption of liquid biopsy diagnostics, an increasing demand for regenerative medicine applications, the advancement of sophisticated exosome isolation technologies, and a heightened focus on precision therapeutic development.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12346&type=smp

Which Drivers Are Advancing The Exosome Diagnostic And Therapeutic Market Growth?

The increasing occurrence of chronic illnesses is anticipated to fuel the expansion of the exosome diagnostic and therapeutic market moving ahead. A chronic disease is defined as a condition persisting for three months or longer, which may progressively worsen over time. Exosomes, utilized in diagnostic and therapeutic contexts, serve as potential biomarkers in cancer, enabling more precise disease monitoring and thereby enhancing the accessibility of personalized medicine. For instance, data from January 2023, published by the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, indicates that by 2050, the global population affected by chronic diseases will reach 142.66 million. Consequently, the growing prevalence of chronic diseases is a key factor propelling the exosome diagnostics and therapeutics market.

Which Segment Divisions Form The Structure Of The Exosome Diagnostic And Therapeutic Market?

The exosome diagnostic and therapeutic market covered in this report is segmented –

1) By Product: Instruments, Software, Reagents And Kits

2) By Application: Diagnostics, Therapeutic

3) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Clinics, Other End Users

Subsegments:

1) By Instruments: Exosome Isolation Systems, Characterization Instruments, Analysis Devices

2) By Software: Data Analysis Software, Exosome Profiling Software

3) By Reagents And KITS: Isolation KITS, Characterization Reagents, Assay KITS

What Trends Are Driving Changes In The Exosome Diagnostic And Therapeutic Market?

Leading companies in the exosome diagnostic and therapeutic market are creating advanced products, such as sample purification systems, to cater to wider customer bases, enhance sales, and boost revenue. A sample purification system consists of a range of procedures and technologies designed to eliminate contaminants and impurities from a sample, including DNA, RNA, proteins, or other biomolecules. For instance, in February 2023, Biological Dynamics Inc., a US-based biotechnology firm, unveiled ExoVerita, an exosome-isolation platform intended for early disease monitoring and various other applications. The ExoVita Pancreas assay identifies specific exosomal protein markers and has demonstrated its capability to detect Stage 1 and Stage 2 pancreatic ductal adenoma carcinoma (PDAC) using blood-based exosome samples enriched by the patented ExoVerita apparatus. The company intends to utilize this validation to analyze samples from the ExoLuminate registry trial (NCT05625529), which has actively begun recruiting patients with high-risk PDAC to evaluate the test’s clinical significance. Individuals presenting with clinical indicators like pancreatitis or known pancreatic lesions, those with a genetic or familial predisposition, and newly diagnosed diabetics over 50 are also eligible.

Which Key Players Are Active In The Exosome Diagnostic And Therapeutic Market?

Major companies operating in the exosome diagnostic and therapeutic market are Thermo Fisher Scientific Inc., Miltenyi Biotec GmbH, Malvern Instruments Inc., System Biosciences LLC, NanoSomix Inc., Exosome Diagnostics Inc., Evox Therapeutics Ltd., ExCoBio Inc., Codiak BioSciences Inc., Capricor Therapeutics Inc., Aethlon Medical Inc., NX Pharmagen Inc., Aegle Therapeutic Corporation, Ciloa, Sistemic Inc., Theoria Science, Mantra Bio Inc., Lonza Group AG, Bio-Techne Corp.

Access The Complete Exosome Diagnostic And Therapeutic Market Report:

https://www.thebusinessresearchcompany.com/report/exosome-diagnostic-and-therapeutic-global-market-report

Which Region Accounts For The Highest Share Of The Exosome Diagnostic And Therapeutic Market?

North America was the largest region in the exosome diagnostic and therapeutic market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the exosome diagnostic and therapeutic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Exosome Diagnostic And Therapeutic Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=12346&type=smp

Browse Through More Reports Similar to the Global Exosome Diagnostic And Therapeutic Market 2026, By The Business Research Company

Exosome Research Market Report 2026

https://www.thebusinessresearchcompany.com/report/exosome-research-global-market-report

Exosome Technologies Market Report 2026

https://www.thebusinessresearchcompany.com/report/exosome-technologies-global-market-report

Lysosomal Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/lysosomal-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795